About
Joined the investment team as Principal in 2024. Previously Senior Director of Business Development & Licensing at Bayer Pharmaceuticals and worked in Boehringer Ingelheim's external innovation group and Roche R&D.
Contact· self-published, not guessed
Experience
- AMR Action FundPrincipalcurrent2024 — presentBoston, USA
- BayerSr. Director, BD&L2022 — 2024Boston, Massachusetts, United States
- Boehringer IngelheimSenior Associate Director, External Innovation2016 — 2022Cambridge, Massachusetts
- Roche PharmaceuticalsAcademic Research Manager2015 — 2016Greater Boston Area
- Roche PharmaceuticalsGroup Leader, Biochemistry2009 — 2014
- University of California, San FranciscoPostdoctoral fellow2005 — 2009
- GenentechVisiting Scientist2005 — 2006
Skills & more
Drug DiscoveryDrug DevelopmentGlobal Alliance ManagementInfectious DiseasesBiochemistryAssay DevelopmentHigh Throughput ScreeningAntibodiesSmall MoleculesExternal InnovationSearch and Evaluation
From Junjun's professional profile.
Deals · 1
Trellis BioscienceLed round
via AMR Action Fund · filed Jan 2026
Attribution from SEC filings, press coverage, and firm rosters.
Colleagues at AMR Action Fund
Bill Burns
Board Chair at AMR Action Fund
Carly Levine
Senior Associate at AMR Action Fund
Chris Sweeney
Executive Director, Communications and Media Relations at AMR Action Fund
Corinna Ruppli
Office Manager at AMR Action Fund
David Hellmuth
General Counsel and COO at AMR Action Fund
Deepali Patel
Director of International Policy at AMR Action Fund
Dorothy Maloney
Compliance Officer at AMR Action Fund
Henni-Karoliina Ropponen
Venture Analyst at AMR Action Fund
Frequently asked questions
- Who is Junjun Gao?
- Joined the investment team as Principal in 2024. Previously Senior Director of Business Development & Licensing at Bayer Pharmaceuticals and worked in Boehringer Ingelheim's external innovation group and Roche R&D.
- Where does Junjun Gao work?
- Junjun Gao is Principal at AMR Action Fund.
- Where did Junjun Gao go to school?
- Junjun Gao studied at The University of Texas at Austin (Ph.D., Molecular Biology); Wuhan University (B.Sc, Biochemistry).
Same school
Also attended The University of Texas at Austin558
Michael DellFounder & CEO of Dell TechnologiesViswa SankaranarayananVenture Partner at Monta Vista CapitalTodd KleinManaging Partner, Revolution Growth at RevolutionSapna MehtaInvestor at RevolutionAnish AggarwalInvestor at LightbankAndrew ScottSenior Finance Manager at Greycroft
+ 552 more
Also attended Wuhan University11
Zhi YangManaging Partner at BVCFShumo ChuEntrepreneur, Computer Scientist & Angel Investor at Shumo ChuSun LilinPartner at BODLPeiyu ZhaoDeal Manager, Loan Origination at KildeHubert ChuVenture Partner at Sapien Ventures / Sapien GroupHualin ZhouAID | Investment Director at Decent Capital
+ 5 more
Shared employers
Also worked at AMR Action Fund10
Aleks EngelPartner at Novo HoldingsAlex GrootenSenior Manager, Head of Accounting at Novo HoldingsMartin HeideckerCIO at AMR Action FundCarly LevineSenior Associate at AMR Action FundJohn VancuraCFO at AMR Action FundHenni-Karoliina RopponenVenture Analyst at AMR Action Fund
+ 4 more
Also worked at Bayer86
Vincent RoseInvestment Manager at Burda Principal InvestmentsJulie YangInvestor at Third Rock VenturesTracy WilliamsInvestor at Third Rock VenturesBenjamin BrockwellVenture Partner at Copper Sky CapitalVincent RulandEntrepreneur-in-Residence at Versant VenturesJeffrey M. HurstInvestor at Commonwealth Venture Management Corp.
+ 80 more
Also worked at Boehringer Ingelheim40
Nick FutrellSenior Associate at Northpond VenturesElias QuijanoPrincipal at Northpond VenturesKazuhiko NonomuraPartner at Remiges Ventures, Inc.Drew GonzalesInvestor at Side Door VenturesEmilio Erazo-FischerOperating Partner at Asabys PartnersShinobu SuzukiScientific Advisor at RDiscovery
+ 34 more
Also worked at Roche Pharmaceuticals119
Joe HorsmanInvestor at Madrona Venture GroupMarco PrunottoInvestor at MedicxiMike FitzgeraldInvestor at High AlphaUri LopatinInvestor at Khosla VenturesJan-Olivier FillolsSenior Managing Director at Marlin Equity PartnersJules D'AssonvilleCo-Founder at InnoCom Bio Equities
+ 113 more